➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Merck

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GRALISE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for GRALISE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01301001 A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee Health Science Center N/A 2012-08-01 The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01301001 A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee N/A 2012-08-01 The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01623271 Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise) Terminated Massachusetts General Hospital N/A 2013-05-01 The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with certain types of neuropathic pain without causing too many side effects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for GRALISE

Condition Name

Condition Name for GRALISE
Intervention Trials
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1
Irritable Bowel Syndrome 1
Quality of Life 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for GRALISE
Intervention Trials
Head and Neck Neoplasms 2
Syndrome 2
Somatoform Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GRALISE

Trials by Country

Trials by Country for GRALISE
Location Trials
United States 9
Lebanon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for GRALISE
Location Trials
New York 3
Illinois 2
North Carolina 1
Massachusetts 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GRALISE

Clinical Trial Phase

Clinical Trial Phase for GRALISE
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for GRALISE
Clinical Trial Phase Trials
Completed 4
Recruiting 3
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GRALISE

Sponsor Name

Sponsor Name for GRALISE
Sponsor Trials
Depomed 2
National Cancer Institute (NCI) 1
University of Tennessee 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for GRALISE
Sponsor Trials
Other 10
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Merck
Express Scripts
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.